James T. Parsons is Director at DiaMedica Therapeutics Inc. (DMAC). They have made 3 open-market trades across 3 companies since 2018, most recently 2026-03-11.
CIK 0001759855
2 open-market purchases totalling $19K since 2018, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DMAC | 97,949 | $745K |
| TRIL | 8,505 | $164K |
| ONCY | 41,849 | $21K |
| Total | $930K |
Shares reported on the most recent Form 4, priced at the 2026-03-13 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.